About Firalis Molecular Precision
Trusted by Biotech, Pharma, Academic Research, and Health organizations, Firalis Molecular Precision is a leading provider of tailored and holistic multi-omics approaches across the entire drug development pipeline, with precision and regulatory expertise.
Our DNA
At the core of our values lies a commitment to fostering collaboration and crafting tailored innovative solutions for academia, research organizations, and biopharmaceutical companies, recognizing the unique challenges and opportunities each sector presents.
Unique solutions
Swift turnaround times
Steadfast collaboration
Cost-effectiveness
Regulatory compliance
Innovative technologies
Global presence
Client-centric approach
Our solutions
From genomics and proteomics to data integration and assay production, our cutting-edge services are all designed to accelerate your research and streamline your drug development process.
BioAnalytical Services
Associated Services
Support throughout the whole pipeline
An essential step in drug development
FMP plays a pivotal role in drug development’s discovery phase, leveraging advanced expertise and cutting-edge technologies to craft customized bioanalytical strategies for discovery programs.
Leveraging a holistic multi-omic approach, we delve deep into biomarker/target discovery and validation, laying the foundation for robust disease understanding.
Our expertise extends to elucidating the intricate mechanisms of action underlying various diseases, empowering pharmaceutical and biotechnology companies throughout this critical phase.
Solutions for safety and efficacy investigation
In pre-clinical research, we offer comprehensive services from early to late stages.
Our expertise includes biomarker studies, drug safety and efficacy assessments, drug concentration quantification, and custom assay development.
Leveraging both in vitro and in vivo experiments, we rigorously evaluate the effects of drugs to ensure thorough understanding and informed decision-making throughout the drug development process.
Comprehensive support across trial phases
In clinical development, our support spans phases 1 to 3, encompassing a wide array of services.
We investigate short-term adverse reactions, evaluate drug activity, measure efficacy, and discover prognostic and diagnostic biomarkers.
We also initiate CDx development, evaluate drug effects and adverse events, and validate drug response signatures and biomarkers clinically.
Furthermore, we conduct CDx CoU validation and develop custom assays, ensuring comprehensive assistance throughout the clinical trial journey.
Support throughout post-market surveillance
In the post-approval phase, we remain steadfast in our commitment to ensuring the ongoing safety and efficacy of approved treatments.
Our comprehensive post-market surveillance program includes diligent monitoring of long-term biomarker efficacy, safety profiles, and the balance of risks and benefits associated with the use of pharmaceutical products. Leveraging advanced technologies and methodologies, we conduct thorough assessments to identify any emerging concerns and promptly address them to safeguard patient well-being. Additionally, we undertake the production of CDx kits, facilitating the integration of personalized medicine approaches into clinical practice and enhancing patient care outcomes.
From samples to insights
Uncovering insights requires going beyond data generation. It requires an approach that analyzes multiple layers of information simultaneously.
Our team of experts can support you throughout your R&D from samples to insights.
Study Planning
Sample Collection – Kick-off design – Scientific support
Sample Management
Quality Control – Labelling – Barcoding – Blinding
LIMS Registry > Freezing (-4 to -150°C) > Monitoring (24/7)
Pre-Analytical Services
Sample Aliquoting – DNA/RNA Extraction – Custom Protocols
Sample Analysis
Genomics – Epigenomics – Transcriptomics – Proteomics – Metabolomics
Data Analysis
Bioinformatics & ML – Statistics – Internal Data Storage
Insights Reporting
Raw Data – Custom Analysis – Data Visualization
What our clients say about us
Our clients’ feedback speaks to the quality and care we put into our work.
” Thanks for the smooth analysis of our first samples. It was brilliant! “
Giusy Di Conza, PhD
” The Firalis Molecular Precision teams have demonstrated remarkable dynamism and flexibility in preparing quotes, as well as in explaining the procedures for sample transfer and processing. The quality of the data received was excellent, and the announced timelines were strictly adhered to. Communication with your technical teams was seamless and efficient, greatly facilitating the progress of the project. “
Franck Verdonk, MD, PhD
” I have worked with Firalis Molecular Precision for the analysis of our plasma samples, and their service has met my expectations. Their team was competent and attentive to our specific needs. The analyses were carried out on schedule and provided useful information for the progress of our work. I recommend Firalis Molecular Precision for their reliability and expertise in proteomics. “
Flavien Delhaes, PhD
” For our OMICs experiments we trust Firalis Molecular Precision. They provided us with good quality results in a very timely manner. “
Vincent Anquetil, PhD
” Firalis Molecular Precision has been an outstanding collaborative partner to NeuroTherapia in designing and executing proteomics studies related to our Phase 1b clinical trial. We highly recommend them for their high-quality services, precise and rigorous data analysis capabilities, and prompt, reliable communication. We look forward to working with them again in the future. “
Marianna Kiraly, PhD
Scientific insights and news
